HomeLYEL • NASDAQ
add
Lyell Immunopharma Inc
Previous close
$0.92
Year range
$0.85 - $3.26
Market cap
269.25M USD
Avg Volume
1.93M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 34.00K | 36.00% |
Operating expense | 50.54M | -14.43% |
Net income | -44.58M | 12.33% |
Net profit margin | -131.13K | 35.54% |
Earnings per share | — | — |
EBITDA | -45.82M | 15.04% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 440.55M | -23.44% |
Total assets | 619.22M | -22.11% |
Total liabilities | 88.52M | -9.13% |
Total equity | 530.70M | — |
Shares outstanding | 279.22M | — |
Price to book | 0.45 | — |
Return on assets | -19.83% | — |
Return on capital | -20.77% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -44.58M | 12.33% |
Cash from operations | -35.04M | 7.02% |
Cash from investing | 1.92M | -98.08% |
Cash from financing | 0.00 | 100.00% |
Net change in cash | -33.12M | -153.56% |
Free cash flow | -17.72M | 18.61% |
About
Founded
2018
Headquarters
Website
Employees
224
